The TNFAIP3 locus at 6q23, encoding A20, has been associated with multiple autoimmune diseases (AIDs). In this study, we sequence the coding portions of the gene to identify contributing causal polymorphisms that may explain some of the observed associations. A collection of 123 individuals from the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection, each with multiple AIDs (mean ¼ 2.2 confirmed diagnoses), and 397 unrelated healthy controls were used for initial sequencing. A total of 32 polymorphisms were identified in the sequencing experiments, including 16 novel and 11 coding variants. Association testing in the entire MADGC collection (1,008 Caucasians with one or more AIDs and 770 unaffected family controls) revealed association of a novel intronic insertion-deletion polymorphism with rheumatoid arthritis (RA) (odds ratio (OR) ¼ 2.48, P ¼ 0.041). Genotyping of the most common coding polymorphism, rs2230926, in the MADGC collection and additional control individuals revealed a significant association with Sjögren's syndrome (OR ¼ 3.38, P ¼ 0.038), Crohn's disease (OR ¼ 2.25, P ¼ 0.041), psoriasis (OR ¼ 0.037, P ¼ 0.036) and RA (OR ¼ 1.9, P ¼ 0.025). Finally, haplotype and additional testing of polymorphisms revealed that cases were enriched for 5 0 and 3 0 untranslated region variants (one-sided P-value ¼ 0.04), but not specifically for common (42% minor allele frequency), rare, exonic, intronic, non-synonymous or synonymous variants.
Introduction
Autoimmune diseases (AIDs) are characterized by misidentification of self as foreign with a resultant immune response that attacks one's own cells and organs. Inheritance patterns have been studied for many of these disorders and they are generally accepted as having a genetic component to susceptibility. Genetic predisposition is multifactorial and disease incidence varies from rare (for example, idiopathic thrombocytopenic purpura has a population prevalence of 0.08% in US adults) to common (rheumatoid arthritis (RA) has a US population prevalence of 1%; see the study by Helmick 1 ). Although AIDs affect different systems or organs, it has been frequently observed that these diseases can cluster in families and even within individuals. One example is a study of AID clustering in families with multiple sclerosis (MS) described by Barcellos et al. 2 With such overlapping disease prevalence, it is not surprising that several genetic loci have been associated with more than one AID. The hallmark locus is the major histocompatibility complex region on chromosome six, which has an important role in autoimmunity. Another locus is the TNFAIP3 gene and surrounding genomic region, which has to date been associated with RA, [3] [4] [5] systemic lupus erythematosus (SLE), [6] [7] [8] [9] [10] [11] [12] psoriasis, 13 celiac disease, 14, 15 type I diabetes, 16 ulcerative colitis, 17 Crohn's disease 18 and juvenile idiopathic arthritis. 19 This gene encodes A20, a protein involved in inhibiting signals from the tumor necrosis factor, Toll-like receptor and nucleotide-binding oligomerization domain pathways. [20] [21] [22] [23] Dysregulation of these pathways results in inflammation and programmed cell death.
With the exception of missense polymorphism rs2230926 (F127C) in SLE 6, 7, 11 and RA, 11 associations to date have been identified outside the coding regions of the gene. One explanation for such associations is that polymorphisms are in linkage disequilibrium with putatively causal polymorphisms that were not genotyped directly. We sought to identify such variants for these AID associations by sequencing the coding portions of the gene in individuals from the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection. 24 This collection includes families affected by more than one AID, and in this study, we perform sequencing in individuals who are themselves affected by more than one disease. This sample set provides an opportunity to search for variants that may be relevant to more than one AID, as shown for the PTPN22 AID associations using this same collection.
24
TNFAIP3 (NM_006290), at 6q23, is composed of nine exons with a non-coding exon one and partially coding exon nine. The 790 amino acids include an N-terminal cysteine protease OTU domain (Cys103) and seven C-terminal zinc-finger motifs that perform its deubiquitination and ubiquitination functions, 25 respectively. In this study, we sequence 123 individuals each affected with multiple AIDs and 397 healthy controls. We also perform genotyping of the most common coding polymorphism, rs2230926, which has previously been associated with SLE and RA, and a novel insertion-deletion variant identified here in the entire MADGC collection.
Results

Sequencing of TNFAIP3 in cases and controls
We identified 33 polymorphisms through the sequencing of 246 case and 794 control chromosomes (Table 1) . One was dropped from analysis for being out of the HardyWeinberg equilibrium (rs3214646) and probably does not represent a true polymorphic locus. In all, 11 were in the protein-coding regions: 8 of these were non-synonymous and 3 were synonymous. The synonymous singlenucleotide polymorphism (SNP), Leu725Leu, is located in zinc-finger motif six. Overall, 16 were novel, or not in the public database dbSNP Human Build 131, including 9 of the coding variants. Seven variants failed to sequence and thus were missing from the controlsequencing data and one from the case sequencing data and were not included in comparisons between cases and controls. For the two variants detected in cases only, rs5029964 was in one of two family members sequenced and novel_2 was in an individual with no other family members sequenced.
Association testing of sequenced variants
Fisher's exact tests of association were performed for 24 SNPs and insertion-deletion polymorphisms and empirical P-values calculated through permutation ( Table 2) . Comparison of 91 Caucasian, unrelated, multiply affected individuals with 397 controls revealed significant association for one intronic insertion-deletion An omnibus test for association of 24-marker haplotypes with a frequency at least 1% was highly significant, with a P-value of 2.9 Â 10
À05
. Keeping the haplotype frequency threshold of X1% revealed three significant haplotypes, none of which contained the risk allele of Novel_4 (data not shown). When we included haplotypes of all frequencies, eight reached significance given an a-value of 0.05 and one was borderline significant (Table 3 contains results for these nine haplotypes). Two of these haplotypes contained the risk allele of Novel_4 Table 2 with rs5029940 coded as A/C and novel_4 coded as C/A. Minor alleles present in each haplotype are in bold red colour and SNP rs2230926 is in bold black text (all haplotypes have the major, protective allele). Overall, 91 unrelated, multiply affected, Caucasian MADGC cases vs 397 healthy controls.
TNFAIP3 sequencing and association with multiple AIDs SL Musone et al and none contained the risk allele for rs2230926, the previously associated coding polymorphism. In addition, we tested for differences in polymorphisms between cases and controls with weighted sum analysis and found cases to be enriched for 5 0 and 3 0 untranslated region variants (one-sided P-value ¼ 0.04), but not for common (42% minor allele frequency), rare, exonic, intronic, non-synonymous or synonymous variants.
Association testing of novel_4 and rs2230926
We further evaluated novel_4 and rs2230926 SNPs by testing associations in the full MADGC collection, in particular for the presence of multiple AIDs, any AID and individual AIDs versus healthy controls. To prevent false positives due to population stratification, we also tested the significance of three ancestry informative markers (AIMs) 28 with rs2230926 and novel_4 genotypes and between control groups. None of the AIMs were significantly associated with rs2230926 or novel_4 genotypes, suggesting that stratification is not a problem in these analyses.
First, to confirm the association of novel_4 with multiple AID diagnoses, the insertion-deletion polymorphism was genotyped in all Caucasian individuals in the MADGC collection, which included 1008 affected participants and 770 unaffected family controls ( Table 4 ). Software that can account for the relatedness among MADGC cases and controls was used for association testing (see the 'Materials and methods' section). Significant association with multiple AID diagnoses was not observed (P ¼ 0.337; N cases ¼ 142), but the OR remained well over 1 (OR ¼ 1.67, 95% CI: 0.61-4.57). However, the novel_4 variant was significantly associated with RA (OR ¼ 2.48, P ¼ 0.041; N cases ¼ 146).
As the coding SNP rs2230926 was previously associated with SLE, we genotyped this variant in the same group of Caucasian individuals in the MADGC collection, as described above for the novel_4 variant. We also genotyped this coding SNP in an additional 743 unrelated healthy Caucasian controls from a study of MS 26 and the SOPHIE (Study of Pharmacogenetics in ethnically diverse populations) collection 27 ( Table 5 ). The largest OR observed was for Sjö gren's syndrome (N ¼ 18; P ¼ 0.038; OR ¼ 3.38), followed by Crohn's disease (N ¼ 50; P ¼ 0.041; OR ¼ 2.25), psoriasis (N ¼ 78; P ¼ 0.037; OR ¼ 2.17) and RA (N ¼ 148; P ¼ 0.025; OR ¼ 1.9). However, these results should be interpreted with caution given the limited sample sizes for individual AIDs.
Discussion
This study represents, to our knowledge, the first comprehensive screening of coding exons of TNFAIP3, which encodes A20. We have sequenced a population affected by multiple AIDs, given published association with several individual diseases. In addition, we performed more extensive genotyping and association testing of the previously associated coding SNP TNFAIP3 sequencing and association with multiple AIDs SL Musone et al rs2230926 and a novel insertion-deletion polymorphism among a larger group of Caucasian AID patients and control individuals.
We identified 32 polymorphisms, 16 novel and 11 coding, in cases and controls. One of the novel polymorphisms (novel_4), which is an intronic insertion-deletion polymorphism, was significantly associated with the risk of RA based on our analysis of individuals enrolled in the MADGC collection. These results warrant validation in other collections.
The previously identified coding SNP in exon 3 (rs2230926) was significantly associated with the risk of Sjö gren's syndrome, Crohn's disease, psoriasis and RA among individuals enrolled in the MADGC collection. We did not observe significant association with SLE, and this may be due to the lack of power as we had very low power (o25%, for a ¼ 0.05), given our observed OR and the number of SLE cases in this family collection. This could also reflect differences between SLE that arises in the context of such multiplex (for diverse AIDs) families compared with SLE cases from individual AID collections. It is interesting to note that the difference in ORs for the autoimmune thyroid diseases, Hashimoto's thyroiditis (0.84) and Graves' disease (1.55), are quite striking, suggesting differential association with these distinct diseases. Our results do not provide any evidence of association of this variant with MS, also suggesting differential effects across AIDs as has been observed with the PTPN22 missense SNP.
Given the fact that multiple variants within the TNFAIP3 genomic region have been associated with AIDs in the current and previous studies, we examined haplotypes across this region. We identified nine haplotypes significantly or marginally associated with multiple AID diagnoses, and thus combinations of alleles seem to be important in conferring risk to multiple AIDs. Cases were found to be enriched for 5 0 and 3 0 untranslated region variants compared with controls, indicating that perhaps splicing or translational control are important for the function of this gene and its role in disease. In choosing to focus on coding exons in this study, we may have missed potentially important polymorphisms in non-coding regulatory regions. In summary, overall, our results support an important role for variants in the TNFAIP3 gene region in the development of human AID. However, the pattern of genetic association appears to be complex, with multiple variants contributing differentially across the spectrum of AID. Additional work will be required to confirm novel associations reported in this study and to identify polymorphisms in non-coding regions that may contribute to risk of autoimmunity.
Materials and methods
DNA collections
We sequenced 123 individuals from the MADGC collection who were affected by two or more individual AIDs. To be eligible for enrollment in the MADGC collection, families had to have at least two members with confirmed diagnoses of at least one of nine 'core' AIDs. Details of MADGC recruitment and enrollment procedures have been described previously. 24 The 4 most common AID combinations among the 123 individuals sequenced were the presence of Hashimoto's thyroiditis with one of the following: RA (N ¼ 19) , SLE (N ¼ 11), MS (N ¼ 15) or type I diabetes (N ¼ 12) . The mean AID count was 2.2 with a maximum of 6. The numbers of affected individuals per disease are listed in Table 6 for the nine core diseases plus an extra category termed 'other AIDs', which includes other confirmed diagnoses outside the core nine. Hashimoto's thyroiditis and Grave's disease were counted as a single core disease, autoimmune thyroid disease, but were analyzed separately in this study. Most subjects were Caucasian (N ¼ 108), 11 were Caucasian/Native American, 1 was Caucasian/Asian and 3 were Hispanic. A total of 18 families had multiple members sequenced (38 individuals), whereas the remaining 85 individuals had no relatives sequenced in this study. For association testing, 1 member of each family was randomly selected and the 91 unrelated Caucasian cases (of the 123 sequenced individuals) were compared with 397 healthy Caucasian controls who were enrolled at the University of California San Francisco and included individuals from the SOPHIE collection (N ¼ 262). All subjects gave informed consent in accordance with the Institutional Review Board at their respective institutions.
Sequencing
To sequence all protein-coding bases, eight sequencing reactions were performed for each DNA sample. Four sets of PCR primers were from SeattleSNPs (http://pga.gs.washington.edu/), whereas the other four were designed using Primer3. 29 Detailed primer TNFAIP3 sequencing and association with multiple AIDs SL Musone et al information can be found in Table 7 . Primer sets were checked through ePCR on the UCSC genome browser to ensure one unique genomic hit and were also inspected for a lack of known SNPs with dbSNP. PCR was performed with 8 ng DNA, 0.4 mM each forward and reverse primer, 1 Â buffer, 4 mM dNTPs and 0.3 Units Qiagen (Valencia, CA, USA) HotStar Taq in a 10 ml reaction. PCR was cleaned up by incubation with 1 Â SAP PCR Clean-Up Reagent (Perkin-Elmer Life Sciences Inc., Waltham, MA, USA) at 37 1C for 1 h. Sequencing reactions contained 2.5 ml of clean PCR product, 0.375 mM primer and 8.3% Applied Biosystems (ABI; Foster City, CA, USA) BigDye Terminator v3.1 in a 12 ml reaction. Excess dye terminator removal was performed using genCLEAN (Genetix, New Milton, Hampshire, UK) plates following the manufacturer's instructions before sequencing on an ABI 3730 Â L DNA Analyzer. Sequencing was performed in one direction, except for regions with insertion-deletion polymorphisms and novel polymorphisms which were confirmed by sequencing the other strand.
Genotyping
Genotyping of indel Novel_4 and SNP rs2230926 was conducted in the entire MADGC collection (Caucasians; N ¼ 1778), including 1008 affected participants and 770 unaffected family controls. For rs2230926, additional healthy Caucasian controls were from the SOPHIE collection (N ¼ 257) and from a study of MS, which included Northern European-derived individuals with no family history of MS (N ¼ 486). Three AIMs were genotyped to assess population stratification. Genotyping was performed using a predesigned ABI TaqMan assay for SNP rs2230926 and for the three AIMs (rs1042712, rs7696175 and rs9378805) and a custom TaqMan design for Novel_4 following the manufacturer's protocol. We used 2 Â PCR Universal Master Mix and 4.5 ng DNA in a 5 ml reaction. Duplicates and no template controls were checked for quality control purposes.
Statistical methods
Sequencing traces were analyzed using Sequencher (Gene Codes, Ann Arbor, MI, USA). Hardy-Weinberg equilibrium P-values were calculated in Haploview 30 to assess sequencing quality, and a P-value of 0.001 was used as the significance threshold for exclusion. Individual polymorphism tests for association between sequenced cases and controls were conducted in Plink. 31 We used Fisher's exact test and also conducted adaptive permutation tests by swapping the case-control status to calculate empirical P-values for each variant. To mitigate the potential for false positives due to population stratification, we restricted the analysis to Caucasian samples, and we trimmed the panel to unrelated individuals, which reduced the number of cases from 123 to 91.
A single haplotype block was defined using the spine of linkage disequilibrium definition in Haploview. Haplotype tests for association were conducted in Plink for 24-variant combinations for all frequencies and also restricted to those with a frequency 41%. The 24 variants were polymorphic in cases or controls when the cases were restricted to unrelated Caucasians.
A weighted sum statistic was calculated to test for association with disease for a group of variants, each of which might have an independent influence on a genetically heterogeneous trait. This approach of combining independent signals has been shown to be significantly more powerful than variant-by-variant approaches. In addition, mechanistic interpretations can be more readily made when the variants are grouped based on the functional elements in which they reside. We used a custom script according to the method of Madsen and Browning. 32 We checked for differences in common (42% minor allele frequency), rare, exonic, intronic, non-synonymous, synonymous and untranslated region variants between cases and controls.
Association testing for novel_4 and rs2230926 in the larger collection was conducted using PedGenie 33 to account for the relatedness among the MADGC collection cases and controls. AIM association testing was performed in Plink, and Hardy-Weinberg equilibrium P-values were checked in Haploview with criteria as described above. As many AIDs are represented in the MADGC collection, only the most common AIDs were individually tested for association, with Sjögren's syndrome being the least frequent. Abbreviations: Amp. coordinates, amplicon positions on chromosome 6, UCSC hg19; PD, primer design software/source.
TNFAIP3 sequencing and association with multiple AIDs SL Musone et al of these samples for rs2230926. WL was supported by a grant from the Dermatology Foundation. We also thank Drs Peter Gregersen and Timothy Behrens for their important contributions to the MADGC study (supported by N01 AI95386). LAC was also supported by K24 AR02175 and a Kirkland Scholar Award.
